We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

News

Personalized Medicine Can Cut Breast Cancer Risk

The time has come for breast cancer risk assessment, counseling and genetic testing to move from cancer specialists to the realm of primary care, according to a presentation at the AAAS annual meeting.
News

ImmunoCellular Therapeutics Completes Acquisition of Molecular Antibody Technology

The technology acquired consist a platform technology referred to by MDC as DIAAD™ and certain monoclonal antibody candidates to detect and treat cancer.
News

Scientists Find Antibody that can Potently Neutralize Two Viruses

NCI scientists have discovered an antibody that neutralizes two highly infectious viruses classified as henipaviruses.
News

Biomoda and Medical Acoustics Partner in Study for Early Detection of Lung Cancer in Veterans

Biomoda and Medical Acoustics will collect lung sputum samples in an upcoming clinical study that will use Biomoda's proprietary testing technology for detection of early lung cancer.
News

Schering-Plough and OraSure Sign International Collaboration for Point-of-Care Oral Hepatitis C Test

New agreement provides for development and promotion of OraQuick® HCV test outside the United States.
News

Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests

Vermillion obtains exclusive rights the development of biomarkers that can be applied toward disease detection, classification and monitoring of prevalent cancers.
News

Ipsogen Reports Recommendation of JAK2V617F Mutation Screening in WHO 2008 Criteria and Point-of-Care Diagnostic Algorithms

The 2008 revision of the WHO document on the classification of CMPDs has incorporated new information on the molecular pathogenesis of BCR–ABL negative myeloproliferative disorders including the screening for JAK2V617F mutation.
News

20/20 Licenses Lung Cancer Blood Test to Ortho-Clinical Diagnostics

The company has entered into an agreement with Ortho-Clinical Diagnostics to license certain 20/20 intellectual property relating to a blood test for the early detection of lung cancer.
News

LabCorp Licenses Technology for Early Detection of Lung Cancer from Duke University

LabCorp enters into an exclusive license agreement to commercialize Duke's new blood-based assay for early detection of lung cancer.
News

Common Molecule Notifies Immune System of Prostate Cancer

In experiments with mice, researchers have found that the body's immune system can use a surprisingly common molecule to recognize prostate tumors.
Advertisement